Economy

Repros Therapeutics Inc. (NASDAQ:RPRX) Signals 'Overbought' Based on Its RSI

Repros Therapeutics Inc. has been given an analysts' mean target of 5.5. (RPRX) escalated 64.8% and closed its last trading session at $0.53.

Looking into last 5 trades, the stock observed a return of nearly 65.63%. The company's market cap is $19.94 million. The company has 37.5 Million shares outstanding and 37.36 Million shares were floated in market. For the most recent quarter, quick ratio was 1.80, current ratio was 1.80, LT Debt/Equity ratio was - and Total Debt/Equity ratio stands at -, while Payout ratio is 0.

Repros Therapeutics Inc. (NASDAQ:RPRX) touched its 1-Year High price of $2.180 on 10/07/16 and its 1-Year Low price of $0.260 on 08/22/17. The company has experienced volume of 2,525,238 shares while on average the company has a capacity of trading 3.58M share. Looking further out we can see that the stock has moved -59.85% over the year to date. It sustained ROA (TTM) at -212.10%.

Equity Research firms now have a positive stance on shares of Fenix Parts, Inc. Its weekly performance showed upward trend of 65.63 percent. Its Average True Range (ATR) shows a figure of 0.05.

Liquidity ratios help investors to determine a company's ability to pay off its debts. The Beta for the stock stands at 0.38.

Repros Therapeutics Inc. (NASDAQ:RPRX) shares are moving 29.83% trading at $0.69 today.

In order to check on the sell-side rational, we can also take a peek at some technical indicators. The stock closing price is now trading upward to its 50 day moving average with change of 68.60%, escalated to its 20 day moving average with figure of 67.85% and behind its 200 day moving average with value -32.72%. Institutional owners hold 20.10% stake in the company while Insiders ownership held at 0.20%. The mean target price as estimated by the analysts for the company has been recorded at $91.11. The company beat the analyst EPS Estimate with the difference of $0.01.

EPS growth for the next 5 years is 27.9 percent. A stock that maintains a relatively stable price has low volatility. It indicates oversold and overbought price levels for a stock.

Repros Therapeutics, Inc is a biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive system disorders.

A statistical measure of the dispersion of returns (volatility) for RPRX producing salvation in Investors mouth, it has week volatility of 30.97% and for the month booked as 14.87%.

Repros Therapeutics Inc. (NASDAQ:RPRX) gross margin percentage stands at 0% while its operating margin for the past trailing twelve month is 0 percent and its overall profit margin (ttm) is 0 Percent.

The company last reported its quarterly results on Nov 13 BMO. Analysts have a mean recommendation of 2.00 on this stock (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range). The company now has a Return on Equity of 8.20% and Return on Investment of 5.70%.



Like this

loading...
loading...

Latest


10 October 2017
Multiple tornadoes believed to have caused damage northwest of Charlotte
American Red Cross officials estimate that 30 homes were damaged and have opened a shelter at South Caldwell High School. If you have any photos or video of Sunday's storm or the damage they caused, send them to fox46pix@foxtv.com.

10 October 2017
Chiefs WR Chris Conley ruptured Achilles during win over Texans
Harris has largely been a non-factor in Kansas City's passing game since arriving in the National Football League in 2014. Conley is now third on the team in receiving yards with 175, but without a touchdown to show.

10 October 2017
Myer is offering free shipping for Christmas
It's called Shipster and it's something the Australian market has been needing for a long time. Mr Balbin said about 60 million U.S. households have signed up for the Amazon Prime service.

10 October 2017
Odisha Likely To Witness Heavy Rain, With Depression Likely To Intensify
Landing of 47 in-bound flights and departure of about 35 flights was rescheduled and many flights were delayed, an official said. During this period, the system has moved further west-northwestwards and at present, it is seen close to Bankura .

10 October 2017
Tuesday is deadline to register to vote in Ohio
Any mailed materials must be received at a board of elections by October 18, when any voter address changes also must be received. NY has a closed primary system, meaning that, for example, only registered Democrats can vote in Democratic primaries.

10 October 2017
Las Vegas and guns
Cramer, have remained relatively silent on gun legislation after offering their condolences following the tragedy in Vegas. What the NRA and right-wing politicians have exploited is the cultural divide between gun owners and advocates for reform.

10 October 2017
PNC Financial Services Group Inc (NYSE:PNC) 2017 Q2 Sentiment Report
Finally, Stratos Wealth Partners LTD. increased its stake in shares of PNC Financial Services Group by 41.7% in the third quarter. The Firm is formed to grow a portfolio of natural gas terminaling, processing, storage, transportation and related assets.

10 October 2017
Revenue Estimates Analysis QUALCOMM Incorporated (QCOM)
Deprince Race & Zollo Inc acquired 195,951 shares as Qualcomm Inc ( QCOM)'s stock rose 2.14%. (NASDAQ: QCOM ) for 19,347 shares. CFO4Life L.P. bought a new position in shares of QUALCOMM during the third quarter worth $205,000. (NASDAQ: QCOM ).

10 October 2017
The Value of Synchronoss Technologies, Inc. (NASDAQ:SNCR) Underpriced or Overpriced?
Similarly, Price to cash flow ratio is another helpful ratio in determining a company's value. (NasdaqGS: SNCR ) has a Q.i. Shares of Synchronoss Technologies ( SNCR ) traded down 3.11% on Monday, reaching $13.71. (NasdaqGS: SNCR ) is 4.845098.

10 October 2017
Analysts' Review under Consideration: Silver Spring Networks Inc Co (SSNI)
Shares of Pdl Biopharma Inc (NASDAQ:PDLI) soared 1.78% or 0.06 to reach at $3.44 during previous trading session. On September 22 the company was downgraded from "Outperform" to "Neutral" in a report issued by FBR Capital.